AKR1C enzymes sustain therapy resistance in paediatric T-ALL


Despite chemotherapy intensification, a subgroup of high-risk paediatric T-cell acute lymphoblastic leukemia (T-ALL) patients still experience treatment failure. In this context, we hypothesised that therapy resistance in T-ALL might involve aldo-keto reductase 1C (AKR1C) enzymes as previously reported for solid tumors. Expression of NRF2-AKR1C signaling… (More)
DOI: 10.1038/s41416-018-0014-0


5 Figures and Tables

Slides referencing similar topics